ArticleCancer science2020

Glycogen synthase kinase-3 inhibition overcomes epithelial-mesenchymal transition-associated resistance to osimertinib in EGFR-mutant lung cancer.

Koji Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.